Oramed Pharmaceuticals Inc.
ORMP
$2.11
-$0.04-1.86%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -26.02% | -12.41% | -18.70% | 1.69% | 14.87% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 24.55% | 140.41% | -28.83% | -30.69% | -64.79% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -25.76% | -11.91% | -18.74% | 1.52% | 14.14% |
|
|
|||||
| Total Current Assets | -25.76% | -11.91% | -18.74% | 1.52% | 14.14% |
| Net Property, Plant & Equipment | -29.01% | -29.04% | -28.80% | -25.52% | -24.58% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 15,233.33% | 0.00% | 0.00% | -9.09% | 16.13% |
| Total Assets | -27.55% | -29.60% | -28.50% | 17.85% | 27.46% |
|
|
|||||
| Total Accounts Payable | -59.83% | 43.19% | 95.04% | 320.65% | -68.75% |
| Total Accrued Expenses | 101,300.00% | 6.72% | -- | -- | 0.00% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -28.74% | -19.10% | -3.19% | 5.93% | 4.96% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -83.63% | -89.32% | -93.25% | 249.86% | 574.90% |
|
|
|||||
| Total Current Liabilities | -83.63% | -89.32% | -93.25% | 249.86% | 574.90% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -55.88% | -54.39% | -52.19% | -51.64% | -51.77% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -50.45% | -0.29% | 0.02% | -0.10% | 0.17% |
| Total Liabilities | -79.84% | -82.78% | -88.44% | 42.59% | 293.80% |
|
|
|||||
| Common Stock & APIC | 0.75% | 0.47% | 0.89% | 1.46% | 1.64% |
| Retained Earnings | -18.10% | -12.10% | 2.61% | 12.44% | 6.28% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -15.50% | -10.72% | 4.90% | 16.84% | 10.38% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -15.50% | -10.72% | 4.90% | 16.84% | 10.38% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 0.00% | 1.08% | -1.88% | -2.24% | -11.68% |
| Total Equity | -15.58% | -10.77% | 4.92% | 16.93% | 10.37% |
|
|
|||||